Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd
Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Phase 2 | 2025-10-02 | NCT07203521 | |
| RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Phase 1 / Phase 2 | 2025-09-30 | NCT07166380 |